Literature DB >> 33222147

Hippocampal Sector-Specific Metabolic Profiles Reflect Endogenous Strategy for Ischemia-Reperfusion Insult Resistance.

Olga Krupska1,2, Tomasz Kowalczyk3, Małgorzata Beręsewicz-Haller1, Paulina Samczuk3, Karolina Pietrowska3, Krzysztof Zabłocki2, Adam Kretowski3, Michal Ciborowski4, Barbara Zabłocka5.   

Abstract

The gerbil is a well-known model for studying cerebral ischemia. The CA1 of the hippocampus is vulnerable to 5 min of ischemia, while the CA2-4 and dentate gyrus (DG) are resistant to it. Short-lasting ischemia, a model of transient ischemic attacks in men, results in CA1 neuron death within 2-4 days of reperfusion. Untargeted metabolomics, using LC-QTOF-MS, was used to enrich the knowledge about intrinsic vulnerability and resistance of hippocampal regions and their early post-ischemic response (IR). In total, 30 significant metabolites were detected. In controls, taurine was significantly lower and guanosine monophosphate was higher in CA1, as compared to that in CA2-4,DG. LysoPG and LysoPE were more abundant in CA1, while LysoPI 18:0 was detected only in CA2-4,DG. After IR, a substantial decrease in the citric acid level in CA1, an accumulation of pipecolic acid in both regions, and opposite changes in the amount of PE and LysoPE were observed. The following metabolic pathways were identified as being differentially active in control CA1 vs. CA2-4,DG: metabolism of taurine and hypotaurine, glycerophospholipid, and purine. These results may indicate that a regulation of cell volume, altered structure of cell membranes, and energy metabolism differentiate hippocampal regions. Early post-ischemia, spatial differences in the metabolism of aminoacyl-tRNA biosynthesis, and amino acids and their metabolites with a predominance of those which upkeep their well-being in CA2-4,DG are shown. Presented results are consistent with genetic, morphological, and functional data, which may be useful in further study on endogenous mechanisms of neuroprotection and search for new targets for therapeutic interventions.

Entities:  

Keywords:  CA1; Gyrus dentatus; Hippocampus; Ischemia-reperfusion injury; LC-QTOF-MS; Meriones unguiculatus; Transient ischemic episode; Untargeted metabolomics

Year:  2020        PMID: 33222147     DOI: 10.1007/s12035-020-02208-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  37 in total

Review 1.  Lipids and lipidomics in brain injury and diseases.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher; R J Dempsey
Journal:  AAPS J       Date:  2006-05-05       Impact factor: 4.009

2.  De novo sequencing and initial annotation of the Mongolian gerbil (Meriones unguiculatus) genome.

Authors:  Diego A R Zorio; Scott Monsma; Dan H Sanes; Nace L Golding; Edwin W Rubel; Yuan Wang
Journal:  Genomics       Date:  2018-03-08       Impact factor: 5.736

3.  Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Diabetic Rats via Enhanced Post-Ischemic Mitochondrial Dysfunction.

Authors:  Vibha Shukla; Perry Fuchs; Allen Liu; Charles H Cohan; Chuanhui Dong; Clinton B Wright; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Transl Stroke Res       Date:  2018-03-22       Impact factor: 6.829

Review 4.  Genomic approach to selective vulnerability of the hippocampus in brain ischemia-hypoxia.

Authors:  Rainald Schmidt-Kastner
Journal:  Neuroscience       Date:  2015-09-14       Impact factor: 3.590

5.  Resveratrol Preconditioning Induces Genomic and Metabolic Adaptations within the Long-Term Window of Cerebral Ischemic Tolerance Leading to Bioenergetic Efficiency.

Authors:  Nathalie Khoury; Jing Xu; Samuel D Stegelmann; Charles W Jackson; Kevin B Koronowski; Kunjan R Dave; Juan I Young; Miguel A Perez-Pinzon
Journal:  Mol Neurobiol       Date:  2018-10-20       Impact factor: 5.590

Review 6.  Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models.

Authors:  Nilendra Singh; Megha Agrawal; Sylvain Doré
Journal:  ACS Chem Neurosci       Date:  2013-06-24       Impact factor: 4.418

7.  Potential serum biomarkers and metabonomic profiling of serum in ischemic stroke patients using UPLC/Q-TOF MS/MS.

Authors:  Hongxue Sun; Jiaying Zhao; Di Zhong; Guozhong Li
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

8.  Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling.

Authors:  Hamed Amani; Rouhollah Habibey; Fereshteh Shokri; Seyed Javad Hajmiresmail; Omid Akhavan; Alireza Mashaghi; Hamidreza Pazoki-Toroudi
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

9.  Tissue-Specific Metabolic Profiles After Prolonged Cardiac Arrest Reveal Brain Metabolome Dysfunction Predominantly After Resuscitation.

Authors:  Jaewoo Choi; Muhammad Shoaib; Tai Yin; Gautam Nayyar; Koichiro Shinozaki; Jan F Stevens; Lance B Becker; Junhwan Kim
Journal:  J Am Heart Assoc       Date:  2019-08-31       Impact factor: 5.501

10.  Transcriptomics and proteomics analyses of the PACAP38 influenced ischemic brain in permanent middle cerebral artery occlusion model mice.

Authors:  Motohide Hori; Tomoya Nakamachi; Randeep Rakwal; Junko Shibato; Tetsuo Ogawa; Toshihiro Aiuchi; Tatsuaki Tsuruyama; Keiji Tamaki; Seiji Shioda
Journal:  J Neuroinflammation       Date:  2012-11-23       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.